drugset

drugset / Trial / NCT01260285

The Safety of Vardenafil in Patients Undergoing Cardiac Surgery

NCT01260285 ↗

Phase 1 Completed 10 enrolled McGuire Research Institute

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety of vardenafil in cardiac surgery patients.

Timeline

Start: 2010-12
Primary completion: 2011-10
Completion: 2011-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Vardenafil	Small molecule	10 mg	Oral

Indications